The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality
about
Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patientsFibrotic and sclerotic manifestations of chronic graft-versus-host diseaseDisease severity and mortality can be independently regulated in a mouse model of experimental graft versus host diseaseCurrent issues in chronic graft-versus-host disease.Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium studyProlonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host diseaseInterleukin-10 spot-forming cells as a novel biomarker of chronic graft-versus-host disease.Understanding chronic GVHD from different anglesPhase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity.Validation of the EBMT Risk Score for South Brazilian Patients Submitted to Allogeneic Hematopoietic Stem Cell Transplantation.High frequency of CD29high intermediate monocytes correlates with the activity of chronic graft-versus-host disease.Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study.Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD.Extracellular vesicles as potential biomarkers of acute graft-vs.-host-disease.Classification systems for chronic graft-versus-host disease.Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.NIH-defined graft-versus-host disease and evidence for a potent graft-versus-leukemia effect in patients with acute lymphoblastic leukemia.Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen.
P2860
Q26787230-2945124A-D9C6-409C-84EA-81A81B30024FQ27024147-B8A0988C-DD1D-46D9-A0EF-3A6EEFE00EE1Q27314927-B8DB2168-C008-49A3-8874-FD9CE490AFCCQ33917187-E05C2E4E-1CCD-45CE-A8E6-7DDDE8DE38D1Q35794478-739B9A81-636A-4610-82BA-B6CB061D9F80Q35800856-7EF80893-9859-4229-B1A0-1C6B5CA14300Q36498345-DB3189B6-4F34-46BC-BE97-AA56381E9D43Q36551588-B8DB74FB-49E5-4409-B4DB-2FAC0D410953Q36813127-754F9FE5-C476-42CC-A7C5-B8A970FC26F1Q37113099-31BA3E27-DC6E-42A9-9328-3E4B7EBFBB14Q37313795-98C0363F-1081-4A3D-90F2-F59EAFE0C02EQ37422385-2180B566-6496-409D-906B-6552B731078EQ37436451-E4612C12-B0BB-447B-BF89-CA60BA894E8AQ37495327-4E0C51E5-3A5A-4A2B-8A85-0E70812BB57BQ37684622-148D061B-3683-47EE-90C9-503011402439Q38635878-2DA84968-F111-4CED-928E-0F26734DF3DFQ39002161-DB237212-DD0A-44BE-BF1C-734BE20BF3E5Q39393617-ACD3CEB0-32C9-40E7-8BE5-D758F92465FFQ43610177-3DAF9002-FEFD-4C48-B482-55041BBC0DA1Q46343547-AC819ECE-A4D5-465D-AC5B-25B90BC01E73Q50861552-5B75EE3B-3C78-4270-8382-A0447011FA06
P2860
The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The global severity of chronic ...... ival and non-relapse mortality
@ast
The global severity of chronic ...... ival and non-relapse mortality
@en
type
label
The global severity of chronic ...... ival and non-relapse mortality
@ast
The global severity of chronic ...... ival and non-relapse mortality
@en
prefLabel
The global severity of chronic ...... ival and non-relapse mortality
@ast
The global severity of chronic ...... ival and non-relapse mortality
@en
P2093
P2860
P1433
P1476
The global severity of chronic ...... ival and non-relapse mortality
@en
P2093
Brian Betts
Claudio Anasetti
Janelle Perkins
Jongphil Kim
Joseph Pidala
Taiga Nishihori
Teresa Field
P2860
P304
P356
10.3324/HAEMATOL.2011.049841
P577
2011-07-26T00:00:00Z